BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16309220)

  • 1. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
    Pfragner R; Skofitsch G; Höger H; Jech M; Rinner B; Siegl V; Niederle B; Gnant M; Friedl J; Stift A
    Anticancer Res; 2005; 25(6B):4225-30. PubMed ID: 16309220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
    Papewalis C; Wuttke M; Jacobs B; Domberg J; Willenberg H; Baehring T; Cupisti K; Raffel A; Chao L; Fenk R; Seissler J; Scherbaum WA; Schott M
    Horm Metab Res; 2008 Feb; 40(2):108-16. PubMed ID: 18283628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell vaccination in medullary thyroid carcinoma.
    Stift A; Sachet M; Yagubian R; Bittermann C; Dubsky P; Brostjan C; Pfragner R; Niederle B; Jakesz R; Gnant M; Friedl J
    Clin Cancer Res; 2004 May; 10(9):2944-53. PubMed ID: 15131029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
    Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma.
    Bachleitner-Hofmann T; Friedl J; Hassler M; Hayden H; Dubsky P; Sachet M; Rieder E; Pfragner R; Brostjan C; Riss S; Niederle B; Gnant M; Stift A
    Oncol Rep; 2009 Jun; 21(6):1585-92. PubMed ID: 19424640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells.
    Li Z; Sturm S; Svejda B; Höger H; Schraml E; Ingolic E; Siegl V; Stuppner H; Pfragner R
    Anticancer Res; 2008; 28(5A):2705-13. PubMed ID: 19035299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination.
    Schott M; Seissler J; Lettmann M; Fouxon V; Scherbaum WA; Feldkamp J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4965-9. PubMed ID: 11600571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
    Messina M; Robinson BG
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer.
    Papewalis C; Wuttke M; Seissler J; Meyer Y; Kessler C; Jacobs B; Ullrich E; Willenberg HS; Schinner S; Baehring T; Scherbaum WA; Schott M
    Clin Cancer Res; 2008 Jul; 14(13):4298-305. PubMed ID: 18594013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative and pro-apoptotic effects of Uncaria tomentosa in human medullary thyroid carcinoma cells.
    Rinner B; Li ZX; Haas H; Siegl V; Sturm S; Stuppner H; Pfragner R
    Anticancer Res; 2009 Nov; 29(11):4519-28. PubMed ID: 20032400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of anti-tumor response by JAWS II mouse dendritic cells transduced with murine interleukin 12 genes.
    Pajtasz-Piasecka E; Rossowska J; Szyda A; Krawczenko A; Dus D
    Oncol Rep; 2007 May; 17(5):1249-57. PubMed ID: 17390073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.
    Bachleitner-Hofmann T; Stift A; Friedl J; Pfragner R; Radelbauer K; Dubsky P; Schüller G; Benkö T; Niederle B; Brostjan C; Jakesz R; Gnant M
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1098-104. PubMed ID: 11889172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.